133 related articles for article (PubMed ID: 25534323)
21. Hematopoietic stem cells and hematopoiesis.
Smith C
Cancer Control; 2003; 10(1):9-16. PubMed ID: 12598852
[TBL] [Abstract][Full Text] [Related]
22. JAK2 and MPL mutations in myeloproliferative neoplasms.
Koppikar P; Levine RL
Acta Haematol; 2008; 119(4):218-25. PubMed ID: 18566540
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Clonal Hematopoiesis.
Steensma DP
Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
[TBL] [Abstract][Full Text] [Related]
24. Aspp1 Preserves Hematopoietic Stem Cell Pool Integrity and Prevents Malignant Transformation.
Yamashita M; Nitta E; Suda T
Cell Stem Cell; 2015 Jul; 17(1):23-34. PubMed ID: 26119234
[TBL] [Abstract][Full Text] [Related]
25. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.
Shizuru JA; Negrin RS; Weissman IL
Annu Rev Med; 2005; 56():509-38. PubMed ID: 15660525
[TBL] [Abstract][Full Text] [Related]
27. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
[TBL] [Abstract][Full Text] [Related]
28. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.
Coombs CC; Zehir A; Devlin SM; Kishtagari A; Syed A; Jonsson P; Hyman DM; Solit DB; Robson ME; Baselga J; Arcila ME; Ladanyi M; Tallman MS; Levine RL; Berger MF
Cell Stem Cell; 2017 Sep; 21(3):374-382.e4. PubMed ID: 28803919
[TBL] [Abstract][Full Text] [Related]
29. Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency.
Ikeda K; Ueda T; Yamasaki N; Nakata Y; Sera Y; Nagamachi A; Miyama T; Kobayashi H; Takubo K; Kanai A; Oda H; Wolff L; Honda Z; Ichinohe T; Matsubara A; Suda T; Inaba T; Honda H
Sci Rep; 2016 Jul; 6():29454. PubMed ID: 27432459
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies.
Warr MR; Pietras EM; Passegué E
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(6):681-701. PubMed ID: 21412991
[TBL] [Abstract][Full Text] [Related]
31. IDH1 mutations disrupt blood, brain, and barriers.
Shih AH; Levine RL
Cancer Cell; 2012 Sep; 22(3):285-7. PubMed ID: 22975371
[TBL] [Abstract][Full Text] [Related]
32. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells.
Loughran SJ; Kruse EA; Hacking DF; de Graaf CA; Hyland CD; Willson TA; Henley KJ; Ellis S; Voss AK; Metcalf D; Hilton DJ; Alexander WS; Kile BT
Nat Immunol; 2008 Jul; 9(7):810-9. PubMed ID: 18500345
[TBL] [Abstract][Full Text] [Related]
33. Musashi 2 in hematopoiesis.
de Andrés-Aguayo L; Varas F; Graf T
Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
[TBL] [Abstract][Full Text] [Related]
34. Hematopoiesis, stem cells, and transplantation. What have we learned for the new millennium.
Maloy BJ
J Intraven Nurs; 2000; 23(5):298-303. PubMed ID: 11847741
[TBL] [Abstract][Full Text] [Related]
35. Telomeres and telomerase in hematologic neoplasia.
Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
[TBL] [Abstract][Full Text] [Related]
36. Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).
Kitamura T; Watanabe-Okochi N; Enomoto Y; Nakahara F; Oki T; Komeno Y; Kato N; Doki N; Uchida T; Kagiyama Y; Togami K; Kawabata KC; Nishimura K; Hayashi Y; Nagase R; Saika M; Fukushima T; Asada S; Fujino T; Izawa Y; Horikawa S; Fukuyama T; Tanaka Y; Ono R; Goyama S; Nosaka T; Kitaura J; Inoue D
J Biochem; 2016 Jan; 159(1):17-25. PubMed ID: 26590301
[TBL] [Abstract][Full Text] [Related]
37. The origins of blood: induction of hematopoietic stem cells from different sources.
Saito Y; Ishikawa F
Cell Stem Cell; 2008 Jul; 3(1):8-10. PubMed ID: 18593553
[TBL] [Abstract][Full Text] [Related]
38. Mouse and human embryonic stem cell models of hematopoiesis: past, present, and future.
Chen D; Lewis RL; Kaufman DS
Biotechniques; 2003 Dec; 35(6):1253-61. PubMed ID: 14682061
[TBL] [Abstract][Full Text] [Related]
39. Future challenges for hematopoietic stem cell research.
Spangrude GJ
Biotechniques; 2003 Dec; 35(6):1273-9. PubMed ID: 14682063
[TBL] [Abstract][Full Text] [Related]
40. Polycomb complexes PRC1 and their function in hematopoiesis.
Vidal M; Starowicz K
Exp Hematol; 2017 Apr; 48():12-31. PubMed ID: 28087428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
